No connection

Search Results

TOMZ

BEARISH
$0.53 Live
TOMI Environmental Solutions, Inc. · NASDAQ
Target $3.5 (+556.5%)
$0.5 52W Range $1.2

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 21, 2026
Market cap
$10.95M
P/E
N/A
ROE
-160.0%
Profit margin
-66.5%
Debt/Equity
5.82
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
95%
TOMZ exhibits critical financial distress, highlighted by a Piotroski F-Score of 1/9 and a severe accumulated deficit of $58.1 million. While the company maintains a strong gross margin (54.60%), it is unable to translate this into operating profitability, with an operating margin of -161.87%. The balance sheet is highly leveraged with a Debt/Equity ratio of 5.82 and a dangerously low Quick Ratio of 0.25, indicating a liquidity crisis. Despite a single analyst's 'strong buy' rating and a high price target, the fundamental data and a -85% 5-year price trend suggest a high risk of insolvency or further dilution.

Key Strengths

Strong Gross Margin (54.60%) indicating product value
Diversification into aerospace, aquaculture, and cell/gene therapy
Intellectual property protection with 30+ patents through 2038
Potential catalyst in 510(k) medical device clearance
Trading below book value (P/B 0.80)

Key Risks

Critical financial health (Piotroski 1/9)
Extreme leverage with Debt/Equity at 5.82
Severe liquidity risk (Quick Ratio 0.25)
Negative revenue growth (-4.90% YoY) following pandemic demand collapse
Consistent failure to meet earnings estimates (1/4 beats in last 4 quarters)

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
14
Weak
Value
30
Future
25
Past
10
Health
5
Dividend
0
AI Verdict
High Risk / Speculative
Key drivers: Critical Piotroski Score, High Debt/Equity, Negative Revenue Growth, Severe Price Depreciation
Confidence
90%
Value
30/100

P/B 0.80, P/S 1.94, Graham Number N/A

Positives
  • P/B ratio of 0.80 suggests the stock is cheap relative to assets
Watchpoints
  • Negative earnings make P/E and Graham Number inapplicable
  • Book value may be overstated given the accumulated deficit
Future
25/100

Revenue Growth -4.90%, Forward P/E 8.88

Positives
  • Pipeline of $3M in integration projects
  • Medical device 510(k) pathway
Watchpoints
  • Revenue is declining
  • Dependence on a single brand (SteraMist)
Past
10/100

5Y Change -85%, 1Y Change -29.3%

Positives
  • Brief period of pandemic-driven growth
Watchpoints
  • 5-year price change of -85%
  • Consistent history of operational losses
Health
5/100

Piotroski 1/9, Debt/Equity 5.82

Positives
  • Current Ratio > 1.0
Watchpoints
  • Piotroski F-Score 1/9
  • Debt/Equity 5.82
  • Quick Ratio 0.25
Dividend
0/100

Dividend Yield N/A

Positives
No standout positives identified.
Watchpoints
  • No dividend paid
  • Negative earnings preclude dividend capacity

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$0.53
Analyst Target
$3.5
Upside/Downside
+556.5%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for TOMZ and closest competitors.

Updated 2026-04-20
TOM
TOMI Environmental Solutions, Inc.
Primary
5Y
-85.0%
3Y
-24.3%
1Y
-29.3%
6M
-40.5%
1M
-20.9%
1W
-7.0%
HCA
Huachen AI Parking Management Technology Holding Co., Ltd
Peer
5Y
-94.5%
3Y
-94.5%
1Y
-97.1%
6M
-64.1%
1M
+13.4%
1W
+51.2%
SUG
SU Group Holdings Limited
Peer
5Y
-88.3%
3Y
-88.3%
1Y
-30.0%
6M
-45.4%
1M
-6.4%
1W
-5.2%
ETS
Elite Express Holding Inc.
Peer
5Y
-80.6%
3Y
-80.6%
1Y
-80.6%
6M
-18.4%
1M
+50.9%
1W
-1.6%
ART
Art's-Way Manufacturing Co., Inc.
Peer
5Y
-30.6%
3Y
+11.4%
1Y
+33.3%
6M
-23.3%
1M
-2.6%
1W
-0.4%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
8.88
PEG Ratio
N/A
P/B Ratio
0.8
P/S Ratio
1.94
EV/Revenue
2.54
EV/EBITDA
-3.99
Market Cap
$10.95M

Profitability

Profit margins and return metrics

Profit Margin -66.52%
Operating Margin -161.87%
Gross Margin 54.6%
ROE -159.96%
ROA -28.8%

Growth

Revenue and earnings growth rates

Revenue Growth -4.9%
Earnings Growth N/A
Q/Q Revenue Growth -4.9%
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
5.82
High debt
Current Ratio
1.32
Good
Quick Ratio
0.25
Poor
Cash/Share
$0.0

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.0B
Gross Margin
21.3%
Op. Margin
-161.9%
Net Margin
-177.6%
Total Assets
$0.0B
Liabilities
$0.0B
Equity
$0.0B
Debt/Equity
10.95x
Operating CF
$-0.0B
CapEx
$-0.0B
Free Cash Flow
$-0.0B
FCF Yield
100%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-03-31
$-0.09
-350.0% surprise
2025-11-14
$-0.02
-100.0% surprise
2025-08-14
$-0.06
-100.0% surprise
2025-05-08
$-0.01
+80.0% surprise

Industrials Sector Comparison

Comparing TOMZ against 350 companies in the Industrials sector (24 bullish, 118 neutral, 208 bearish)
Return on Equity (ROE)
-159.96%
This Stock
vs
-25.85%
Sector Avg
+518.8% (Excellent)
Profit Margin
-66.52%
This Stock
vs
7.56%
Sector Avg
-979.7% (Weaker)
Debt to Equity
5.82
This Stock
vs
3.06
Sector Avg
+90.4% (Higher)
Revenue Growth
-4.9%
This Stock
vs
91.71%
Sector Avg
-105.3% (Slower)
Current Ratio
1.32
This Stock
vs
3.3
Sector Avg
-59.9% (Weaker)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

PAUL HAROLD W
Director
Stock Award
2026-01-09
20,000 shares · $15,800
LIM BOH SOON
Director
Stock Award
2026-01-09
10,000 shares · $7,900
FRAGASSO FRANCESCO
Director
Stock Award
2026-01-09
20,000 shares · $15,800
Insider transactions can signal confidence or concerns about company prospects

SEC Filings

Recent regulatory filings from the SEC EDGAR database

8-K
FORM 8-K
2026-04-15

TOMZ filed an 8-K on April 15, 2026, likely to announce its quarterly financial results.

8-K
FORM 8-K
2026-04-08

TOMZ filed a Current Report on April 8, 2026, likely announcing its periodic financial results.

8-K
FORM 8-K
2026-03-31

TOMZ filed an 8-K on March 31, 2026, likely to report its first-quarter financial results.

10-K
FORM 10-K
2026-03-31

TOMI Environmental Solutions reported a net loss of $3.7 million in 2025 and $4.5 million in 2024, resulting in an accumulated deficit of $58.1 million. While the company is expanding its SteraMist technology into new markets and pursuing 510(k) clearance for a medical device, it experienced a revenue decline in 2025 due to the timing of equipment purchases. Primary risks include a history of operational losses and the challenge of achieving sustainable profitability following the decline in pandemic-driven demand.

8-K
FORM 8-K
2026-03-06
8-K
FORM 8-K
2026-01-05
8-K
FORM 8-K
2025-11-21
8-K
FORM 8-K
2025-11-20
10-Q
FORM 10-Q
2025-11-14

TOMZ filed its Form 10-Q on November 14, 2025. While specific financial metrics were not provided in the excerpt, the filing includes disclosures regarding risk factors, unregistered sales of equity securities, and defaults upon senior securities.

8-K
FORM 8-K
2025-11-14
8-K
FORM 8-K
2025-11-12
8-K
FORM 8-K
2025-10-01
DEF 14A
DEF 14A
2025-09-30
8-K
FORM 8-K
2025-09-16
10-Q
FORM 10-Q
2025-08-14
Data sourced from SEC EDGAR. AI summaries generated automatically.

Past News Coverage

Recent headlines mentioning TOMZ from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI
Markets
Profile